π Psychedelic Science 2025: The Integration
Your Complete Guide from Zombie Mushrooms
π Event Overview
Welcome to the world's most extraordinary gathering of psychedelic minds! Psychedelic Science 2025: The Integration represents the fifth edition of what has become the largest psychedelic conference in history. This groundbreaking event promises to be a transformative week that will shape the next era of mental health, medicine, and consciousness exploration.
Building on the phenomenal success of previous gatherings, this year's theme focuses on "The Integration" - exploring how psychedelic research, therapy, and culture are being woven into the broader fabric of society. From cutting-edge clinical trials to policy reform, from Indigenous wisdom to modern therapeutic practices, this conference serves as the nexus where science meets spirit.
π Event Details
- DATES June 16-20, 2025
- LOCATION Colorado Convention Center, Denver, CO
- ATTENDEES 12,000+ Expected
π― Key Features
- π€ 400+ Speakers & Presenters
- π’ 10+ Educational Stages
- π 14 Programming Tracks
- πͺ 100,000+ sq ft Expo Hall
- π¨ 80,000 sq ft Deep Space Arts
β οΈ Important Notice
Registration rates increase seasonally! Early bird pricing is available now, with rates continuing to rise as the conference approaches. Secure your spot today to enjoy the best pricing and support this groundbreaking event.
π Complete 5-Day Agenda
π Monday, June 16, 2025
π Workshop Day 1
In-depth half-day and full-day workshops begin. These intensive sessions offer deep dives into specialized topics with hands-on learning opportunities. Workshop topics span clinical practice, research methodologies, therapeutic techniques, and professional development.
Available as add-on registration for all badge types
π Tuesday, June 17, 2025
π Workshop Day 2
Continuation of intensive workshop programming. Advanced clinical training sessions, certification programs, and specialized skill-building workshops continue throughout the day.
Exhibitor booth setup begins in the afternoon
π Wednesday, June 18, 2025
π Conference Opening Day
8:00 AM - Expo Hall opens to attendees (7:00 AM exhibitor early access)
9:00 AM - Opening keynote presentations across main stages
10:00 AM - 6:00 PM - Full programming across all 14 tracks and 10+ stages
Evening - Opening cocktail reception (cash bar) and networking events
All educational stages, Expo Hall, and Deep Space arts area fully operational
π Thursday, June 19, 2025
π― Peak Programming Day
8:00 AM - Expo Hall opens (7:00 AM exhibitor early access)
9:00 AM - 6:00 PM - Full conference programming across all tracks
Midday - Special focus sessions including Veterans Forum and Statewide Initiatives
Evening - Practitioner and Business networking events in exclusive lounges
Peak day for poster sessions and interactive demonstrations
π Friday, June 20, 2025
π¬ Conference Finale
8:00 AM - Final day Expo Hall opens (7:00 AM exhibitor early access)
9:00 AM - 4:00 PM - Concluding sessions and presentations
Afternoon - Integration sessions and community reflection panels
4:00 PM - Expo Hall closes, exhibitor breakdown begins
Evening - Closing ceremonies and farewell gatherings
Allied events continue throughout Denver into the weekend
π― 14 Programming Tracks
𧬠Basic Science
Latest insights on neuroscience, pharmacology, and chemistry of psychedelics, exploring mechanisms of action.
π Studies
New research spanning clinical trials, naturalistic use, risk & safety, public opinion, and global culture.
π₯ Therapy
Deep discussions for clinicians from intake to integration, ethics, accountability, and delivery of care.
π¬ Trials
Findings from clinical trials studying psychedelics for mental illness and neurological disorders.
πΌ Business
Infrastructure for scaling access: finance, drug development, regulatory, clinics, technology, and institutions.
β Black Liberation
Half-day series on plant medicine supporting Black communities in healing from systemic racism and trauma.
ποΈ Community
Dialogues from unique and intersectional communities about their psychedelic perspectives.
π¨βπ¬ Doblin
Rick Doblin's personal selections focusing on pioneers of psychedelic research, therapy, and culture.
πΏ Plant Medicine
Ethnobotanical practices using psychedelic plants: Indigenous, traditional, spiritual, and contemporary approaches.
ποΈ Policy
Legislative, judicial, and regulatory foundations for safe access and post-prohibition society.
π³οΈ Statewide Initiatives
Single-day forum on state-regulated access systems in Colorado and Oregon.
ποΈ Veterans
Forum for veterans, first responders, and families about psychedelic healing in their communities.
π Society
Intersection of psychedelics with culture, arts, music, media, religion, spirituality, and community.
π Integration
Exploring how psychedelics integrate into broader society, featuring high-profile speakers and big ideas.
π€ Featured Speakers & Thought Leaders
Dr. Bessel van der Kolk
Trauma Expert & #1 NYT Bestselling Author
Renowned psychiatrist and author of "The Body Keeps the Score," Dr. van der Kolk is a pioneer in trauma research and treatment. His groundbreaking work has transformed understanding of PTSD and trauma recovery, making him one of the most influential voices in mental health. His integration of psychedelic therapy into trauma treatment represents a paradigm shift in therapeutic approaches.
Paul Stamets
Mycologist, Author & Founder of Fungi Perfecti
World-renowned mycologist and author of multiple groundbreaking books on mushrooms and their applications. Stamets has revolutionized understanding of fungi's role in ecosystem health and human wellness. His research on psilocybin mushrooms and development of cultivation techniques has made him a central figure in the psychedelic renaissance. As founder of MycoMedica and Fungi Perfecti, he continues advancing mycological science.
Dr. Rick Doblin
Founder & President, MAPS
Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), Dr. Doblin has dedicated over 35 years to advancing psychedelic research and therapy. His visionary leadership has brought MDMA-assisted therapy through Phase 3 clinical trials, positioning it for FDA approval. A Harvard Kennedy School graduate, he's the driving force behind the modern psychedelic research renaissance.
Dr. Robin Carhart-Harris
Neuroscience & Psychopharmacology Researcher, UCSF
Leading neuroscientist whose groundbreaking research has illuminated how psychedelics affect the brain. His work on the "default mode network" and development of the REBUS theory has fundamentally changed scientific understanding of psychedelic mechanisms. Now at UCSF's Carhart-Harris Lab, he continues pioneering research into consciousness and psychedelic therapeutics.
Kyrsten Sinema
Former United States Senator, Arizona
Former U.S. Senator who played a crucial role in advancing psychedelic research legislation. Her bipartisan approach to mental health policy and support for medical research has helped create pathways for psychedelic therapy development. Her political insight provides valuable perspective on navigating regulatory and policy challenges.
Tim Ryan
Former U.S. Congressman & Mental Health Advocate
Former Ohio Congressman and mindfulness advocate who championed mental health initiatives in Congress. Now President & CEO of Celtic Consulting, Ryan has been instrumental in promoting alternative mental health treatments including psychedelic therapy for veterans and first responders. His work bridges political leadership with practical mental health solutions.
Amber Capone
Co-founder & CEO, Veterans Exploring Treatment Solutions (VETS)
Military spouse and advocate who co-founded VETS after witnessing her husband's transformation through psychedelic therapy. Her organization has become a leading voice for veterans' access to alternative mental health treatments. Capone
